Panagora Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Sell
1,719
-2,474
-59% -$486K ﹤0.01% 977
2026
Q1
$822K Buy
4,193
+2,529
+152% +$491K ﹤0.01% 756
2025
Q4
$289K Buy
+1,664
New +$303K ﹤0.01% 1009
2024
Q4
Sell
-5,712
Closed -$887K 1169
2024
Q3
$887K Sell
5,712
-1
-0% -$149 ﹤0.01% 765
2024
Q2
$782K Sell
5,713
-2,414
-30% -$331K ﹤0.01% 797
2024
Q1
$1.08M Sell
8,127
-1,407
-15% -$183K 0.01% 770
2023
Q4
$1.31M Buy
9,534
+2,649
+38% +$348K 0.01% 716
2023
Q3
$839K Hold
6,885
0.01% 832
2023
Q2
$968K Sell
6,885
-151,535
-96% -$20.9M 0.01% 796
2023
Q1
$22.4M Buy
158,420
+63,960
+68% +$9.15M 0.14% 158
2022
Q4
$14.8M Buy
94,460
+261
+0.3% +$37.5K 0.1% 212
2022
Q3
$11.6M Buy
94,199
+86,486
+1,121% +$11.4M 0.08% 226
2022
Q2
$1.03M Sell
7,713
-165
-2% -$22.5K 0.01% 870
2022
Q1
$1.08M Buy
7,878
+3,889
+97% +$542K 0.01% 903
2021
Q4
$690K Sell
3,989
-7,448
-65% -$1.13M ﹤0.01% 1081
2021
Q3
$1.66M Sell
11,437
-164
-1% -$24K 0.01% 756
2021
Q2
$1.53M Sell
11,601
-327
-3% -$42.8K 0.01% 803
2021
Q1
$1.53M Sell
11,928
-7,256
-38% -$894K 0.01% 847
2020
Q4
$2.29M Buy
19,184
+670
+4% +$81.7K 0.01% 657
2020
Q3
$2.12M Sell
18,514
-353
-2% -$41.7K 0.01% 618
2020
Q2
$2.15M Sell
18,867
-2,721
-13% -$289K 0.01% 641
2020
Q1
$1.73M Sell
21,588
-7,665
-26% -$794K 0.01% 634
2019
Q4
$3.12M Buy
29,253
+508
+2% +$53K 0.01% 639
2019
Q3
$3.08M Sell
28,745
-823
-3% -$84.5K 0.01% 599
2019
Q2
$3.01M Buy
29,568
+262
+0.9% +$25.2K 0.01% 663
2019
Q1
$2.63M Sell
29,306
-172
-0.6% -$14.9K 0.01% 724
2018
Q4
$2.46M Buy
29,478
+15,157
+106% +$1.42M 0.01% 709
2018
Q3
$1.54M Sell
14,321
-25,999
-64% -$2.85M 0.01% 940
2018
Q2
$4.43M Sell
40,320
-224,614
-85% -$23.4M 0.02% 574
2018
Q1
$26.6M Sell
264,934
-42,844
-14% -$4.39M 0.1% 188
2017
Q4
$30.3M Buy
307,778
+69,618
+29% +$6.6M 0.11% 195
2017
Q3
$22.3M Buy
238,160
+159,420
+202% +$16.9M 0.09% 232
2017
Q2
$8.75M Buy
78,740
+48,892
+164% +$5.17M 0.04% 443
2017
Q1
$2.93M Buy
29,848
+15,870
+114% +$1.51M 0.01% 737
2016
Q4
$1.28M Sell
13,978
-868
-6% -$74.8K 0.01% 1091
2016
Q3
$1.26M Buy
14,846
+772
+5% +$64.8K 0.01% 1097
2016
Q2
$1.15M Buy
14,074
+446
+3% +$34K 0.01% 1073
2016
Q1
$974K Sell
13,628
-873
-6% -$58.5K ﹤0.01% 1108
2015
Q4
$1.03M Sell
14,501
-419
-3% -$28.2K 0.01% 1048
2015
Q3
$917K Buy
14,920
+681
+5% +$47.6K ﹤0.01% 1065
2015
Q2
$1.03M Sell
14,239
-7,178
-34% -$530K 0.01% 1086
2015
Q1
$1.65M Sell
21,417
-4,688
-18% -$336K 0.01% 855
2014
Q4
$1.75M Buy
26,105
+1,620
+7% +$102K 0.01% 801
2014
Q3
$1.49M Sell
24,485
-18,112
-43% -$1.12M 0.01% 865
2014
Q2
$2.5M Buy
42,597
+1,353
+3% +$79.2K 0.01% 734
2014
Q1
$2.39M Buy
41,244
+4,993
+14% +$268K 0.01% 809
2013
Q4
$1.94M Buy
36,251
+771
+2% +$45.7K 0.01% 886
2013
Q3
$2.19M Buy
35,480
+1,598
+5% +$95.6K 0.01% 784
2013
Q2
$2.05M Buy
+33,882
New +$2.02M 0.01% 766

Other funds holding DGX

Panagora Asset Management's DGX Position: Q2 2026 in Review

Panagora Asset Management reduced its Quest Diagnostics (DGX) stake by 59% in Q2 2026, selling an estimated $486K and leaving 1,719 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Panagora Asset Management first reported a position in DGX in Q2 2013 and has held it in 49 quarters since. The position peaked at $30.3M in Q4 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Panagora Asset Management held 1,719 shares of Quest Diagnostics worth $364K as of Q2 2026.
  • Panagora Asset Management sold 2,474 Quest Diagnostics shares in Q2 2026, an estimated $486K.
  • Quest Diagnostics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #977 holding.
  • Panagora Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 49 quarters since.
  • Panagora Asset Management's Quest Diagnostics position peaked at $30.3M in Q4 2017.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.